MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1

Oncotarget

Volumn 6, Issue 19, 2015, Pages 17404-17416

  Ma, Fei ^a   Song, Hongjiang ^a   Guo, Baoliang ^b   Zhang, Yuxin ^a   Zheng, Yasheng ^c   Lin, Chengchun ^d   Wu, Ying ^e   Guan, Guijie ^e   Sha, Ruihua ^e   Zhou, Qingxin ^b   Wang, Dejun ^f   Zhou, Xinglu ^a   Li, Juan ^b   Qiu, Xiaohui ^d  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c Department of General Surgery Central Hospital of Jiuzhen   (China)

^d FUJIAN MEDICAL UNIVERSITY   (China)

^e MUDANJIANG MEDICAL UNIVERSITY   (China)

^f THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Gastric cancer; MiR 361 5p; RNA induced silencing complex (RISC); Tudor staphylococcal nuclease 1

Indexed keywords

MICRORNA; MICRORNA 361 5P; REGULATOR PROTEIN; STAPHYLOCOCCAL NUCLEASE DOMAIN CONTAINING 1 PROTEIN; UNCLASSIFIED DRUG; MIRN361 MICRORNA, HUMAN; NUCLEAR PROTEIN; SND1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN TARGETING; STOMACH CANCER; ANIMAL; BIOSYNTHESIS; COLORECTAL TUMOR; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; METASTASIS; MORTALITY; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR INVASION; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; MICE; MICE, NUDE; MICRORNAS; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84938223755     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3744     Document Type: Article

References (26)

1. Koumarianou A, Tzeveleki I, Mekras D, Eleftheraki AG, Bobos M, Wirtz R, Fountzilas E, Valavanis C, Xanthakis I, Kalogeras KT. Prognostic Markers in Early-stage Colorectal Cancer: Significance of TYMS mRNA Expression. Anticancer Res. 2014; 34:4949-4962.
2. Patel SS, Floyd A, Doorly MG, Ortega AE, Ault GT, Kaiser AM, Senagore AJ. Current controversies in the management of colon cancer. Curr Probl Surg. 2012; 49:398-460.
3. Zhang Y, Yang P. Wang X-F. Microenvironmental regulation of cancer metastasis by mirnas. Trends Cell Biol. 2014; 24:153-160.
4. Bogachek MV, De Andrade JP, Weigel RJ. Regulation of Epithelial-Mesenchymal Transition through SUMOylation of Transcription Factors. Cancer Res. 2015; 75:11-15.
5. Tutar Y. (Thematic Issue: "miRNA and Cancer; Computational and Experimental Approaches"). Curr Pharm Biotechnol. 2014; 15:429-429.
6. Koutsaki M, Spandidos DA, Zaravinos A. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics. Cancer Lett. 2014; 351:173-181.
7. Kanitz A, Imig J, Dziunycz PJ, Primorac A, Galgano A, Hofbauer GF, Gerber AP, Detmar M. The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma. PLoS One. 2012; 7:e49568.
8. Jariwala N, Rajasekaran D, Srivastava J, Gredler R, Akiel MA, Robertson CL, Emdad L, Fisher PB, Sarkar D. Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (Review). Int J Oncol. 2015; 46:465-473.
9. Santhekadur PK, Akiel M, Emdad L, Gredler R, Srivastava J, Rajasekaran D, Robertson CL, Mukhopadhyay ND, Fisher PB, Sarkar D. Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling. FEBS Open Bio. 2014; 4:353-361.
10. Naumov VA, Generozov EV, Zaharjevskaya NB, Matushkina DS, Larin AK, Chernyshov SV, Alekseev MV, Shelygin YA, Govorun VM. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013; 8:921-934.
11. Santhekadur PK, Das SK, Gredler R, Chen D, Srivastava J, Robertson C, Baldwin AS, Fisher PB, Sarkar D. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221. J Biol Chem. 2012; 287:13952-13958.
12. Emdad L, Janjic A, Alzubi MA, Hu B, Santhekadur PK, Menezes ME, Shen X-N, Das SK, Sarkar D, Fisher PB. Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness. Neuro Oncol. 2014; nou220.
13. Tsuchiya N, Nakagama H. MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis. Mutat Res Fundam Mol Mech Mutagen. 2010; 693:94-100.
14. Surova O, Akbar NS, Zhivotovsky B. Knock-down of core proteins regulating microRNA biogenesis has no effect on sensitivity of lung cancer cells to ionizing radiation. PLoS One. 2012; 7:e33134.
15. Heinrich E-M, Wagner J, Krüger M, John D, Uchida S, Weigand JE, Suess B, Dimmeler S. Regulation of miR-17-92a cluster processing by the microRNA binding protein SND1. FEBS Lett. 2013; 587:2405-2411.
16. Díaz-López A, Moreno-Bueno G, Cano A. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res. 2014; 6:205-216.
17. Nishida T, Egashira Y, Akutagawa H, Fujii M, Uchiyama K, Shibayama Y, Hirose Y. Predictors of Lymph Node Metastasis in T1 Colorectal Carcinoma: An Immunophenotypic Analysis of 265 Patients. Dis Colon Rectum. 2014; 57:905-915.
18. Ishimoto T, Izumi D, Watanabe M, Yoshida N, Hidaka K, Miyake K, Sugihara H, Sawayama H, Imamura Y, Iwatsuki M. Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa. J Gastroenterol. 2014; 1-7.
19. Kiga K, Mimuro H, Suzuki M, Shinozaki-Ushiku A, Kobayashi T, Sanada T, Kim M, Ogawa M, Iwasaki YW, Kayo H. Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection. Nat Commun. 2014; 5:4497.
20. Xia J, Guo X, Yan J, Deng K. The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol. 2014; 140:1451-1456.
21. Zabaleta J. MicroRNA: a bridge from H. pylori infection to gastritis and gastric cancer development. Front Genet. 2012; 3:294.
22. Santos JI, Teixeira AL, Dias F, Gomes M, Nogueira A, Assis J, Medeiros R. Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development. Tumour Biol. 2014; 35:6245-6253.
23. Banno K, Iida M, Yanokura M, Kisu I, Iwata T, Tominaga E, Tanaka K, Aoki D. MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment. ScientificWorldJournal. 2014; 2014:178075.
24. Liu D, Tao T, Xu B, Chen S, Liu C, Zhang L, Lu K, Huang Y, Jiang L, Zhang X. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6 (STAT6). Biochem Biophys Res Commun. 2014; 445:151-156.
25. Wu X, Xi X, Yan Q, Zhang Z, Cai B, Lu W, Wan X. MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition. Med Oncol. 2013; 30:1-12.
26. Armengol S, Arretxe E, Enzunza L, Mula S, Ochoa B, Chico Y, Martínez MJ. The promoter of cell growth-and RNA protection-associated SND1 gene is activated by endoplasmic reticulum stress in human hepatoma cells. BMC Biochem. 2014; 15:25.